These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30951563)

  • 1. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
    Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH
    PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication Study:
    Repass J;
    Elife; 2018 Mar; 7():. PubMed ID: 29533182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
    Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
    World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Bacteroides fragilis and Fusobacterium nucleatum infection and colorectal cancer in Vietnamese patients.
    Nguyen Duy T; Le Huy H; Đao Thanh Q; Ngo Thi H; Ngo Thi Minh H; Nguyen Dang M; Le Huu S; Ngo Tat T
    Anaerobe; 2024 Aug; 88():102880. PubMed ID: 38942229
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
    Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development.
    Zhao Y; Tao Q; Li S; Zheng P; Liu J; Liang X
    Eur J Pharmacol; 2020 Dec; 888():173459. PubMed ID: 32768506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum, immune responses, and metastatic organ diversity in colorectal cancer liver metastasis.
    Shigematsu Y; Saito R; Amori G; Kanda H; Takahashi Y; Takeuchi K; Takahashi S; Inamura K
    Cancer Sci; 2024 Oct; 115(10):3248-3255. PubMed ID: 39140431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.
    Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
    J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Bacterial DNA in Colorectal Cancer Patients: The Potential Role of
    Koliarakis I; Lagkouvardos I; Vogiatzoglou K; Tsamandouras I; Intze E; Messaritakis I; Souglakos J; Tsiaoussis J
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusobacterium nucleatum induces excess methyltransferase-like 3-mediated microRNA-4717-3p maturation to promote colorectal cancer cell proliferation.
    Xu Q; Lu X; Li J; Feng Y; Tang J; Zhang T; Mao Y; Lan Y; Luo H; Zeng L; Xiang Y; Hu L; Zhang Y; Li Q; Deng L; He X; Tang B; Mao X; Zeng D
    Cancer Sci; 2022 Nov; 113(11):3787-3800. PubMed ID: 35984699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.